Floatz logo

(18F)-FP-(+)-DTBZ

Parkinson's Disease

Michael J. Fox Foundation for Parkinson's ResearchSmall moleculePhase 2/3Active
BBB
74/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
75/ 100
Competitive Position
73/ 100

Competitive context

255 Active assets in the Parkinson's Disease cohort.

Asset / SponsorPhaseRating
Safinamide
Zambon SpA
Phase 4A
Cvt-301
Acorda Therapeutics
Phase 3A
Tvp-1012
Guangzhou Henovcom Bioscience Co. Ltd.
Phase 4BBB
Istradefylline
Georgetown University
Phase 4BBB
Pardoprunox
Abbott Products
Phase 3BBB

View all 50 →

Same molecule, other indications

(18F)-FP-(+)-DTBZ is also rated in:

Lewy body dementiaDormant
BB
Indicative ·
65 / 100
View asset →
Alzheimer diseaseDormant
CC
Indicative ·
46 / 100
View asset →
type 2 diabetes mellitusDormant
CC
Indicative ·
42 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →